|
|
|
|
|
by panic
3322 days ago
|
|
The root cause is Purdue Pharma, who successfully marketed the drug to primary care physicians by lying about the risk of addiction: Perhaps knowing that doctors would be vigilant against prescribing drugs with the potential for abuse, Purdue set out to distinguish OxyContin from rivals as soon as it dropped. The cornerstone of its marketing campaign was the drug's incredibly low risk of addiction, an enviable characteristic made possible by its patented time-release formula. Through an array of promotional materials, including literature, brochures, videotapes, and Web content, Purdue proudly asserted that the potential for addiction was very small, at one point stating it to be "less than 1 percent."
(http://theweek.com/articles/541564/how-american-opiate-epide...) |
|